This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea Advanced Institute of Science and Technology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations of Minju Jeong in Parkinson's Disease Treatment.
Introduction
Minju Jeong is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of Parkinson's disease. His innovative approach utilizes advanced techniques to address this challenging condition.
Latest Patents
Minju Jeong holds a patent for a method aimed at treating Parkinson's disease. The patent describes a technique that involves introducing a halorhodopsin protein, a polynucleotide encoding the protein, or a vector containing the polynucleotide into the ventrolateral thalamus (VL) or medial globus pallidus (GPm) neurons of a subject suffering from Parkinson's disease. The method further includes illuminating the VL neurons with green light or exposing them to a T-type Ca channel blocker to inhibit rebound firing of VL neurons. This innovative approach has the potential to treat or prevent Parkinson's disease effectively.
Career Highlights
Minju Jeong is affiliated with the Korea Advanced Institute of Science and Technology, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on the treatment of neurological disorders.
Collaborations
Minju Jeong collaborates with esteemed colleagues, including Jeongjin Kim and Youngsoo Kim. Their combined expertise contributes to the ongoing research and development of innovative solutions in the medical field.
Conclusion
Minju Jeong's contributions to the treatment of Parkinson's disease through innovative methods highlight his role as a leading inventor in the medical research community. His work not only showcases his dedication to advancing science but also offers hope for those affected by this debilitating condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
